Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Kucukoglu, Mehmet; HANTA, İSMAİL; AKDENİZ, BAHRİ; Gullulu, NAZMİYE; Atahan, Ersan; SAYIN, TAMER; Okumus, Gulfer; ÖNEN, ZEYNEP; Yokusoglu, Mehmet; Baygul, Arzu

doi:10.5152/anatoljcardiol.2021.03009

Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Atıf İçin Kopyala

Kucukoglu M. S., HANTA İ., AKDENİZ B., Gullulu S., Atahan E., SAYIN T., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.25, sa.10, ss.721-732, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 10
Basım Tarihi: 2021
Doi Numarası: 10.5152/anatoljcardiol.2021.03009
Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.721-732
Anahtar Kelimeler: pulmonary arterial hypertension, iloprost, treatment outcome, safety, survival, COMBINATION THERAPY, ORAL SILDENAFIL, TARGETED DRUGS, NITRIC-OXIDE, PROSTACYCLIN, METAANALYSIS, INSIGHTS
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).